Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I-II Study of NBTXR3 Activated by Sterostatic Body Radiation Therapy (SBRT) In the Treatment of Liver Cancers

NCT02721056 is registered in ClinicalTrials.gov with Nanobiotix as lead sponsor.

NCT NCT02721056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02721056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I-II Study of NBTXR3 Activated by Sterostatic Body Radiation Therapy (SBRT) In the Treatment of Liver Cancers
Lead sponsor
Nanobiotix
Phase
Phase 1/2
Overall status
Terminated
Start date
January 28, 2016
Completion date
May 6, 2020
Enrollment
23 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer